SLNSW-Cabazitaxel plus carboplatin for the treatment of...-TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6858999

Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1–2 trial

Full title: Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1–2 trial

Author/creator: Corn, Paul G, MD, Heath, Elisabeth I, Prof, Zurita, Amado, MD, Ramesh, Naveen, MS, Xiao, Lianchun, MS, Sei, Emi, PhD, Li-Ning-Tapia, Elsa, MD, Tu, Shi-Ming, Prof, Subudhi, Sumit K, MD, Wang, Jennifer, MD, Wang, Xuemei, MS, Efstathiou, Eleni, MD, Thompson, Timothy C, Prof, Troncoso, Patricia, Prof, Navin, Nicholas, PhD, Logothetis, Christopher J, Prof, Aparicio, Ana M, MD.

Call Numbers:

Record Identifier: TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6858999

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6858999

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1–2 trial

    Record identifier

    TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6858999

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6858999

    Share

    Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1–2 trial

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6858999

    Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1–2 trial

    Full title

    Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1–2 trial

    Author / Creator

    Corn, Paul G, MD ; Heath, Elisabeth I, Prof ; Zurita, Amado, MD ; Ramesh, Naveen, MS ; Xiao, Lianchun, MS ; Sei, Emi, PhD ; Li-Ning-Tapia, Elsa, MD ; Tu, Shi-Ming, Prof ; Subudhi, Sumit K, MD ; Wang, Jennifer, MD ; Wang, Xuemei, MS ; Efstathiou, Eleni, MD ; Thompson, Timothy C, Prof ; Troncoso, Patricia, Prof ; Navin, Nicholas, PhD ; Logothetis, Christopher J, Prof ; Aparicio, Ana M, MD

    Publisher

    England: Elsevier Ltd

    Journal title

    The lancet oncology, 2019, Vol.20 (10), p.1432-1443

    Record Identifier

    TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6858999

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Aged Androgens Anemia Anemia - chemically induced Anorexia Anorexia - chemically induced Antineoplastic Agents - administration & dosage Antineoplastic Agents - therapeutic use Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biomarkers Cancer therapies Carboplatin Carboplatin - administration & dosage Care and treatment Castration Chemotherapy Clinical trials Defects Dehydration Dehydration - chemically induced Diarrhea Diarrhea - chemically induced Fatigue Fatigue - chemically induced Hematology, Oncology, and Palliative Medicine Humans Hypokalemia - chemically induced Intravenous administration Male Maximum Tolerated Dose Medical research Medicine, Experimental Metastases Metastasis Middle Aged Morphology Neoplasm Metastasis Neutropenia Neutropenia - chemically induced Neutrophils Oncology Patients Platinum Prednisone Product development Progression-Free Survival Prostate cancer Prostatic Neoplasms, Castration-Resistant - drug therapy Prostatic Neoplasms, Castration-Resistant - pathology Studies Survival Taxoids - administration & dosage Taxoids - therapeutic use Thrombocytopenia Thrombocytopenia - chemically induced Toxicity Tumors

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6858999

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6858999

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections